In ovarian cancer, circSnx12 inhibits ferroptosis and renders ovarian cancer cells resistant to cisplatin treatment via the miR-194-5p/SLC7A11 axis (Qin et al., 2023). Here, SLC7A11 is linked to ovarian carcinoma.